Latest round: IPO. Guido Oelkers is the President and CEO of Swedish Orphan Biovitrum AB (Sobi), a biopharmaceutical company based in Stockholm.
Guido Oelkers is the President and CEO of Swedish Orphan Biovitrum AB (Sobi), a biopharmaceutical company based in Stockholm. The company focuses on developing and marketing specialty medicines for rare diseases and severe conditions. Oelkers is not a founder of Sobi, which was formed through the merger of Swedish Orphan and Biovitrum.
Full founder directory · Investor directory · Company funding database · Fundraising library